Acromegaly

Analysis of 144 cases of acromegaly with reference to its early diagnosis

肢端肥大症144例分析和早期诊断的探讨

Clinical analysis of treatment of 79 cases with acromegaly

肢端肥大症患者79例临床治疗分析

Changes in skeletal system and mineral metabolism in 40 cases of acromegaly were reported .

报告40例肢端肥大症患者骨质与矿物质变化。

Patients with central sleep apnea syndrome , hypothyroidism and acromegaly , etc.

排除中枢性睡眠呼吸暂停综合征、甲状腺功能低下、肢端肥大症等患者。

Clinical survey of 198 cases of acromegaly

198例肢端肥大症的临床表现

It is unknown whether this observation may reflect a more general increased risk of fractures in acromegaly .

还不知这项观察是否能反映出肢端肥大症的一种更为普遍的骨折风险的增加。

On the criteria predicting the short-term therapeutic effect of bromocriptine on active acromegaly

预测溴隐亭治疗活动性肢端肥大症短期疗效指标的分析

Perioperative nursing of two patients with acromegaly and McCune-Albright syndrome

2例McCune-Albright综合征合并生长激素腺瘤患者的围手术期护理

Secondary diabetes and IGT in the treatment of acromegaly with

溴隐亭治疗肢端肥大症继发糖尿病与糖耐量异常报告

Human adults given growth hormone have suffered from acromegaly ( excess bone growth ) and carpal tunnel syndrome .

成年人给予生长激素，则会造成末端肥大（骨头过度生长）以及腕管综合症。

Studies on the Abnormal Response of Pituitary Somatotroph to Dopaminergic Drugs in Patients with Acromegaly

肢端肥大症患者垂体生长激素细胞对多巴胺能药物反应异常的研究

AIM To investigate the changes in the clinical features of anesthetic management , safety and the incidence of major complications in acromegaly patients .

目的探讨合并肢端肥大症对垂体腺瘤合并肢端肥大症患者的麻醉管理及并发症的发生是否有影响。

Clinical evaluation of bronchial intubation of Bonfils intubation fiberscope in acromegaly patients

肢端肥大患者应用Bonfils纤维喉镜行气管插管的临床评价

Methods : PCR and direct sequencing analysis were used to evaluate the expression of gsp oncogene in 10 patients with active acromegaly .

方法：采用PCR和直接序列分析法评价10例肢端肥大症患者肿瘤组织的gsp癌基因的表达。

Acromegaly was suspected from typical appearance , and confirmed with hormonal examination and imaging of the pituitary mass .

肢端肥大症的确切诊断乃住院中经由外表上特征的观察，血中贺尔蒙的检查及核磁共振图象的发现。

Based on the criterion of cure of acromegaly , postoperative hormone level and imaging examination were used to evaluate the post-operative outcomes .

按肢端肥大症的治愈标准，采用术后激素水平结合影像学复查评价手术疗效。

Several attempts at the medical treatment of acromegaly have also been based on the hypothesis that GRF suppression may reduce GH secretion .

若干药物治疗肢端肥大症的尝试均基于这样的一种假设，即：GRF抑制可减少GH的分泌。

Common body cooling , afraid of the cold , pain and intermittent claudication or acromegaly ulcer and gangrene .

常见肢体发凉、怕冷、疼痛，间歇跛行甚或肢端溃疡和坏疽。

Sleep apnea and active acromegaly

睡眠呼吸障碍与活动性肢端肥大症

126 cases with pituitary GH adenomas presenting symptoms and signs of acromegaly or gigantism were reported .

本文报道垂体生长激素腺瘤126冽，均有肢端肥大症或巨人症的表现。

Many patients with acromegaly develop hypopituitarism as a result of the pituitary adenoma itself or therapies such as surgery and radiotherapy .

许多肢端肥大症患者因垂体腺瘤本身、外科手术或者放疗等因素而发生了垂体功能减退。

GH secreting tumors , which are more common in men , may present with acromegaly in adults and gigantism in children .

生长激素分泌性肿瘤多见于男性，可以出现肢端肥大症（成人）和巨人症（儿童）。

ACTH deficiency , higher doses of hydrocortisone replacement , and radiotherapy are independent predictors of mortality in patients with acromegaly .

促肾上腺皮质激素缺乏、大剂量氢化可的松替代治疗和放疗是肢端肥大症患者死亡率的独立预测因素。

These results have important implications for the treatment of patients with acromegaly and also raise issues as to the optimum hydrocortisone treatment regimens for ACTH-deficient patients .

这些结果为肢端肥大症患者的治疗提供了重要的借鉴，并要求为ACTH缺乏的患者寻求更为合理的氢化可的松用药方法。

Context : The effects of GH replacement in GH-deficient ( GHD ) adults previously treated for acromegaly are not well known .

内容：在原先肢端肥大症治愈继发生长激素缺乏的患者中使用生长激素替代治疗的影响尚不明确。

Somatostatin analogs , such as octreotide , successfully control hormone hypersecretion in patients with acromegaly , islet cell tumors , carcinoids , and control of tumor growth .

生长抑素类似物奥曲肽在肢端肥大症和良、恶性腺细胞肿瘤的患者中能成功地控制激素的高分泌，控制肿瘤的生长。

Methods 135 cases of acromegaly from 1984 to 1997 were analyzed retrospectively , of which 23 cases were complicated by diabetes , 14 cases by hypertension , 5 cases by acromegalic cardiomyopathy .

方法回顾分析1984年到1997年收治的135例肢端肥大症，其中并有糖尿病23例，并有高血压14例，有肢端肥大性心肌病5例；

PRL was elevated in 56.5 % of patients with chromophobe adenoma , in 32.9 % with acromegaly and in 34.6 % with other sellar tumors .

嫌色细胞瘤、肢端肥大症和鞍部其他肿瘤引起PRL升高者分别为56.5%、32.9%和34.6%。